Intera Atlas
Run match
Sites / Epic Medical Research
Is this you?

Request access for Epic Medical Research with your @epicmedresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Epic Medical Research

Unclaimed profile

Site Network · Unknown (appears to be multi-state; operations in TX, OK, LA, AL, AZ, NJ, CA) · ~15-17 facilities across 5 states sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 7Lift (cardio sample) 0.36Recruit soph 0.14
Quality Scorecard (1–100)
Overall68Recruit57Ops71Sponsor71Ther77

Performance (observed)

Historical trials
264
Completed
95
Terminated/Withdrawn
21
Completion rate
82%
Active now
141
Phase 2
91
Phase 3
154
Realized enrollment
316,782
First study year
2007
Years active
19
Match confidence
low
Enrollment velocity (inf)
16,673

Therapeutic

Areas
21+ areas including vaccines, cardiometabolic, neurology, psychiatry, oncology, gastroenterology, infectious disease, MASH/MASLD, respiratory, dermatology, orthopedics, rheumatology
Specialties
Cardiometabolic, Dermatology, Infectious disease, Gastroenterology, Hematology, Neurology, Ophthalmology, Pain, Psychiatry, Respiratory, Vaccines, Bone disease, Device trials, Point-of-care testing
Breadth (conditions)
788
States
Texas (10 locations), Oklahoma, Louisiana, Alabama, Arizona, New Jersey, California

Recruitment (web observed)

Advertises recruitment
Yes
Capability notes
Physician-owned multi-specialty network; 185,000-350,000+ diverse patients; 98.4% patient retention; 138% enrollment targets; 25+ active studies; rapid site activation and consistent quality

Relationships

Sponsors
National Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; SWOG Cancer Research Network; Pfizer; Amgen; Eli Lilly and Company
CROs
ICON plc; IQVIA Pty Ltd; Medpace, Inc.
Owner / parent
Physician-owned; founded 2020 (formally); Dr. Haresh Boghara, MD, MBA and other PIs listed
Expansion
Y (16+ facilities, 6 states: TX, OK, LA, AL, AZ, CA)
Recent hiring
Y (careers page active)

Capacity & people

Investigators
—
Coordinators
—
CEO
Dr. Scott Huff, MD (Principal CEO and CMO)
Emails
Multiple contact emails for different sites

Tech & DCT

Builds tech
Unknown
Tech stack
CLIA-certified labs, centralized operations
Recruiting visible
Y

Notes

Growing multi-state physician-owned site network with 15+ facilities and broad therapeutic portfolio; strong enrollment performance (98.4% retention, 138% targets); 350K+ diverse patient base; recruitment-focused; multiple concurrent studies; broad therapeutic mix including high-volume areas (vaccines, cardiometabolic); newer organization but strong execution; good Intera fit—recruitment-capable, diverse patients, multiple studies, growth trajectory [Validated: 11 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.42Liftability 0.36Overall68

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.